Fundaments of Addiction Medicine. Addiction Medicine Express All of Addiction Medicine in 60 Slides and 60 minutes
|
|
- Avis Shelton
- 5 years ago
- Views:
Transcription
1 1:15 2:3 pm Addiction Medicine Express SPEAKER Petros Levounis, MD, MA Presenter Disclosure Information The following relationships exist related to this presentation: Petros Levounis, MD, MA: No financial relationships to disclose Off-Label/Investigational Discussion In accordance with pmicme policy, faculty have been asked to disclose discussion of unlabeled or unapproved use(s) of drugs or devices during the course of their presentations. Addiction Medicine Express All of Addiction Medicine in 6 Slides and 6 minutes Petros Levounis, MD, MA Chair, Department of Psychiatry Rutgers New Jersey Medical School Learning Objectives 1. Apply neurobiological concepts to treat patients who suffer from substance use disorders 2. Identify intoxication and withdrawal syndromes of alcohol, opioids, and sedatives 3. List three psychosocial and three pharmacological interventions in the treatment of addiction Outline A. Fundamentals of Addiction Medicine B. Assessments and Treatments C. Special Populations and Topics A Fundaments of Addiction Medicine
2 NEUROBIOLOGY OF ADDICTION Natural Rewards and Dopamine Levels Biological Psychological Social Use Brain Switch Addiction % of Basal DA Output Food 15 1 Empty 5 Box Feeding Time (min) DA Concentration (% Baseline) 15 1 Sex Female Present Sample Number Adapted from: Di Chiara, Neuroscience, 1999; Fiorino and Phillips, J Neuroscience, % of Basal Release % of Basal Release 25 Effects of Drugs on Dopamine Levels MORPHINE Dose mg/kg hr NICOTINE % of Basal Release % of Basal Release COCAINE hr ETHANOL Dose (g/kg ip) ALCOHOL GABA CNS Inhibition Glutamate CNS Excitation Opioid Euphoria Dopamine Addiction Serotonin Impulsivity Cannabinoid Pleasant Feeling hr hr Adapted from: Di Chiara and Imperato, Proceedings of the National Academy of Sciences USA, 1988; courtesy of Nora D Volkow, MD. Alcohol Intoxication -1 mg/dl Well-being 1- mg/dl Incoordination -3 mg/dl Ataxia 3-4 mg/dl Stage I Anesthesia 4-6 mg/dl Coma 6-8 mg/dl Death Treat supportively. Alcohol Withdrawal Following the last drink: 6 to 24 hours: Autonomic Hyperactivity 24 to 48 hours: Seizures 48 to 96 hours: Delirium tremens Typically mild, occasionally severe, rarely fatal. Treat with: Mild: Moderate: Severe: Hydration and Rest Oral Chlordiazepoxide (CIWA Protocol) IV Chlordiazepoxide in ICU
3 Alcohol Addiction Dislufiram Naltrexone Acamprosate OPIOIDS 1. Naturally Occurring Opioids Morphine Codeine 2. Semi-Synthetic Opioids Oxymorphone Oxycodone Hydromorphone Hydrocodone Di-Acetyl-Morphine (Heroin) 3. Synthetic Opioids Fentanyl Methadone (Tramadol) Buprenorphine Opioid Intoxication 1. Constricted pupils 2. Constipation 3. Nausea and vomiting (often projectile) 4. Respiratory depression 5. Coma and death Treat with naloxone. Opioid Withdrawal 1. Dilated pupils 2. Diarrhea 3. Flu-like symptoms (rhinorrhea, lacrimation) 4. Yawning 5. Unbearable body aches 6. Sweats and piloerection ( cold turkey ) Treat with methadone or buprenorphine. Opioid Addiction STIMULANTS COCAINE Inhibits Reuptake of synaptic dopamine METH Inhibits Reuptake of synaptic dopamine Promotes Direct dopamine release
4 Stimulant Acute States Stimulant Addiction Intoxication: 1. Euphoria 2. Hypervigilance to frank paranoia 3. Decreased appetite 4. Seizures Withdrawal: 1. Dysphoria 2. Psychomotor retardation 3. Increased appetite Dackis, J Subst Abuse Treat, 212. Please note: This agent is not approved by the FDA for use in cocaine use disorder. CANNABIS Cannabis Acute States Intoxication: If drunk you run the RED lights If stoned you stop at the GREEN lights Withdrawal: Withdrawal syndrome is not: As painful as heroin withdrawal, As dangerous as alcohol withdrawal, or As long-lasting as cocaine withdrawal NSDUH, TEDS, National Seizure System. Cannabis Addiction Therapeutic Potential Pain (cancer, multiple sclerosis) Nausea (cancer) Loss of appetite and wasting (HIV/AIDS) Increased ocular pressure (glaucoma) Inflammation (rheumatoid arthritis, Crohn s disease, ulcerative colitis) Epilepsy Meier, Proc. Natl. Acad. Sci., 212. Volkow, NEJM, 214.
5 TOBACCO Tobacco Addiction Individuals with mental illness or substance use disorders AIDS Obesity Alcohol Motor Homicide Drug Suicide Smoking Vehicle Induced Centers for Disease Control and Prevention, NHIS, 7. Anthenelli, Lancet, 216. BEHAVIORAL ADDICTIONS Both impulsivity and compulsivity show inability to refrain from dysfunctional repetitive behaviors. Impulsivity is driven by an effort to obtain arousal and gratification (norepinephrine and dopamine). Compulsivity is driven by an effort to reduce anxiety (serotonin). Dimensional Approach COMPULSIVE END OCD Body Dysmorphic Disorder Anorexia Nervosa Hypochondriasis Tourette s Syndrome Trichotillomania Autism Binge Eating Compulsive Buying Kleptomania Pathological Gambling Self-Injurious Behaviors Sexual Compulsions Borderline Personality Disorder IMPULSIVE END Antisocial PD Hollander and Stein, Clinical Manual of Impulse-Control Disorders, 6. SSRIs for Alcohol Use Disorder The Behavioral Addictions in 216 6% 5% 4% 3% 2% 1% % Early (n=45) Placebo Late (n=55) Sertraline Abstinence rates during a 14-week treatment trial with sertraline mg QD. Sertraline helped Late- Onset alcoholics stay abstinent, but worsened the condition for Early-Onset alcoholics. 1. Exercise 2. Food 3. Gambling 4. Internet Gaming 5. Internet Surfing 6. Texting and ing 7. Kleptomania 8. Love 9. Sex 1. Shopping 11. Tanning 12. Work Pettinati, Alcohol Clin Exp Res,. Ascher and Levounis The Behavioral Addictions, American Psychiatric Publishing, 215.
6 B Assessments and Treatments SIX TIPS FOR RECOGNIZING ADDICTION 1.Moody 2.Changes in Sleep 3.Changes in Appearance 4.Work Performance 5.Financial Difficulties 6.Abusive Behavior GetHolisticHealth.com SIX TIPS FOR TREATING ADDICTION 1.Alcohol AA 2.Opioids Buprenorphine 3.Stimulants CBT 4.Cannabis MI 5.Tobacco Varenicline 6.All Other CBT SCREENING For Alcohol Use Disorders MEN: 5 or more standard drinks in a sitting. (15 or more per week.) WOMEN: 4 or more standard drinks in a sitting. (8 or more per week.) NIAAA.NIH.gov. Toxicology Urine Toxicology Detection Limits Alcohol Alcohol (Ethyl glucuronide, EtG test) Amphetamines/Methamphetamines Benzodiazepines (Short-acting) Benzodiazepines (Long-acting) Cocaine Heroin (Morphine) Methadone Marijuana (Single use) Marijuana (Long-term heavy use) 7-12 hours 4 days 2 days 3 days 3 days 2-4 days 2 days 3 days 3 days >3 days Adapted from: Staub, Clinical Chemistry, 1. Moeller. Mayo Clin Proc. 8; Anders, et al. Alcohol and Alcoholism, 9.
7 The DSM-5 PHYSIOLOGY The Tolerance Wise Withdrawal THE CORE PROBLEM OF SUBSTANCE USE Know: Knowledge of adverse consequences, yet continued use INTERNAL PREOCCUPATION Decline Desire to cut down Tender Time a great deal of time spent using Loving Larger amounts or longer periods of use than intended Care, Craving EXTERNAL CONSEQUENCES And Activities given up Respect Role obligations neglected Silver Social or interpersonal problems Hair. Hazardous use Levounis. Academic Psychiatry, 215. Substance-Related and Addictive Disorders Alcohol Caffeine Cannabis Hallucinogen Inhalant Opioid Sedative Stimulant Tobacco Gambling Disorder BRIEF INTERVENTION 12-Step Facilitation 1. Be empathic and curious. 2. State your medical findings. 3. Educate about problematic use and addiction. 4. Advise. 5. Follow up. 6. Refer, if necessary. Attitudes and Perceptions MEDICAL STAFF 1. Housing 2. Gov t Services 3. Medical Services 4. Outpatient Tx 5. Job 6. Community 7. Trusting People 8. Inner peace 9. God 1. Spirituality 11. AA PATIENTS 1. Inner peace 2. God 3. Medical Services 4. AA 5. Housing 6. Spirituality 7. Outpatient Tx 8. Community 9. Gov t Services 1. Trusting People 11. Job What Medical Staff Think Patients Think 1. Housing 2. Outpatient Tx 3. Medical Services 4. Job 5. Trusting People 6. AA 7. Inner Peace 8. Community 9. Gov t Services 1. Spirituality 11. God Cognitive Behavioral Therapy 41 Goldfarb, Am J Drug Alcohol Abuse, Levounis and Arnaout, Handbook of Motivation and Change: A Practical Guide for Clinicians, 21.
8 Motivation and Mindfulness Psychiatric Co-Morbidities 1. A third to two thirds of addicted people also suffer from another mental illness not 1%, not 9%. 2. Treat both the addiction and the cooccurring psychiatric disorder(s). 3. Avoid benzodiazepines and use antidepressants as first line treatments for anxiety disorders. Genetics C Special Populations and Topics Di Forti, Biol Psychiatry, 212. Pregnancy Adolescence Jones, N Engl J Med, 21. MonitoringTheFuture.org; Volkow, NEJM, 214.
9 The Elderly The Current Opioid Epidemic 1 1. Addiction is grossly underdiagnosed due to: Reduction in everyday expectations resulting in decreased transgressions Societal stereotype of an addict as a young person Lack of peer group surveillance 2. Sedative and opioid drug-drug interactions are particularly prevalent. Porter and Jick, N Engl J Med, January 1, 198. The Current Opioid Epidemic 2 The Current Opioid Epidemic 3 Compton, N Engl J Med, 216. EMERGING TRENDS Bath Salts % reporting any substance use disorders And Back to Psychodynamics * 11.4 *** *** 13.2 * 9.6 Ref 5.6 Women 17.7 Only same-sex Mostly same-sex Equally both sexes Mostly 18.5other sex Only other 15.7 sex 12.2 Men *p<.5, ***p<.1 based on logistic regression analysis adjusted for race, age, educational level, personal income, employment status, relationship status, health insurance status, geographic location, MSA, age at alcohol onset, and family history of AOD problems. Reference group was heterosexual group. En.Wikipedia.org Courtesy of Sean McCabe, PhD.
Bench to Bedside: From the Science to the Practice of Addiction Medicine
Bench to Bedside: From the Science to the Practice of Addiction Medicine Petros Levounis, MD, MA Chair, Department of Psychiatry Rutgers New Jersey Medical School ADDICTION MEDICINE ACADEMY Clearwater
More informationGambling Disorder as a Behavioral Addiction
Gambling Disorder as a Behavioral Addiction Petros Levounis, MD, MA Chair, Department of Psychiatry Rutgers New Jersey Medical School New York Coalition for Asian American Mental Health NYS Office of Alcoholism
More informationMain Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders
Substance Use Disorders Main Questions Why study addiction? What is addiction? Why do people become addicted? What do alcohol and drugs do? How do we treat substance use disorders? Why study addiction?
More informationLGBT PERSPECTIVES IN ADDICTION MEDICINE
LGBT PERSPECTIVES IN ADDICTION MEDICINE Petros Levounis, MD, MA Director, The Addiction Institute of New York Associate Clinical Professor of Psychiatry, Columbia University College of Physicians & Surgeons
More informationSTIMULANTS. 1980s: Cocaine. Outline. General Roadmap
STIMULANTS Petros Levounis, MD, MA Chair, Department of Psychiatry Rutgers New Jersey Medical School Petros Levounis ASAM Disclosure of Relevant Financial Relationships Content of Activity: ASAM Review
More informationPrepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry
Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry In broad terms, substance use disorders occur when a substance is used in a compulsive manner with a lack of control over
More informationUnderstanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO
Understanding Addiction and Its Impact on the Brain SDSMA Webinar Matthew Stanley, DO Estimated Economic Cost to Society Due to Substance Abuse and Addiction: Illegal drugs: Alcohol: Tobacco: $181 billion/year
More informationAddiction Overview. Diane A. Rothon MD. Causes Consequences Treatments. Methadone/Buprenorphine 101 April 1, 2017
Addiction Overview Causes Consequences Treatments Methadone/Buprenorphine 101 April 1, 2017 Diane A. Rothon MD Why? would you listen to this presentation Review the definition and neurobiology of addiction
More informationNeurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP
Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP Disclosures This speaker has no conflicts of interest to disclose Objectives Define drug abuse and addiction Identify the
More informationMedication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs
Medication Assisted Treatment Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs Disclosures Employed by the Department of Veterans Affairs
More informationPharmacotherapy for Substance Use Disorders
Pharmacotherapy for Substance Use Disorders Vanessa de la Cruz, MD Chief of Psychiatry Mental Health and Substance Abuse Services Santa Cruz County Health Services Agency 1400 Emeline Avenue Santa Cruz,
More informationOpioids. Sergio Hernandez, MD
Opioids Sergio Hernandez, MD Required Slide Disclosures 1. SIGNIFICANT FINANCIAL INTERESTS NO SIGNIFICANT FINANCIAL, GENERAL, OR OBLIGATION INTERESTS TO REPORT 2. GENERAL AND OBLIGATION INTERESTS All general
More informationTobacco Dependence Treatment From Neurobiology through Public Policy
Tobacco Dependence Treatment From Neurobiology through Public Policy Mary Ellen Wewers, PhD, MPH, RN Professor Emerita The Ohio State University College of Public Health Disclosures Funding from the National
More informationPSYCHIATRIC CO-MORBIDITY STEVE SUGDEN MD MPH
PSYCHIATRIC CO-MORBIDITY STEVE SUGDEN MD MPH OVERVIEW: PSYCHIATRIC DISORDERS Mood Disorders Anxiety Disorders Psychotic Disorders Personality Disorders PTSD Eating Disorders EXAMPLE What is the diagnosis?
More informationMedications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?
Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They? Yngvild Olsen, MD, MPH Cecil County Board of Health Workgroup Meeting Elkton, MD October 8, 2013 Objectives
More informationTHE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept.
THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept. Public Health disclosures Dr. Martin has no conflict of interest to disclose.
More informationUnit II Problem 7 Pharmacology: Substance Abuse, Dependence and Addiction
Unit II Problem 7 Pharmacology: Substance Abuse, Dependence and Addiction Drugs are classified as being Used (medically approved) abused (medically NOT approved) - What is the difference between dependence
More informationUnderstanding Addiction: Why Can t Those Affected Just Say No?
Understanding Addiction: Why Can t Those Affected Just Say No? 1 The Stigma of Addiction There continues to be a stigma surrounding addiction even among health care workers. Consider the negative opinions
More informationOpiate Use Disorder and Opiate Overdose
Opiate Use Disorder and Opiate Overdose Irene Ortiz, MD Medical Director Molina Healthcare of New Mexico and South Carolina Clinical Professor University of New Mexico School of Medicine Objectives DSM-5
More informationListen & Hear 4Lo
Mark Lim M.D FASAM Medical Director NorthLakes Community Clinic Recovery Program Board Certified in Family Medicine Board Certified in Addiction Medicine mlim@northlakesclinic.org 7156852200 Listen & Hear
More informationSubstance Use Disorders. A Major Problem. Defining Addiction 2/24/2009. Lifetime rates of alcoholism estimated at 13.4 %
Substance Use Disorders A Major Problem Lifetime rates of alcoholism estimated at 13.4 % Rates of drug abuse estimated at 6% Marijuana is most frequent Approximately 600,000 deaths each year from substance
More informationsubstance use and mental disorders: one, the other, or both?
substance use and mental disorders: one, the other, or both? Stephen Strobbe, PhD, RN, PMHCNS-BC, CARN-AP Dawn Farm Education Series St. Joe s Education Center, Ypsilanti, MI Tuesday, January 27, 2015
More informationADDICTIONS. Mine Özmen, M.D. University of İstanbul Cerrahpaşa School of Medicine Department of Psychiatry
ADDICTIONS Mine Özmen, M.D. University of İstanbul Cerrahpaşa School of Medicine Department of Psychiatry Addictions-terminology drug abuse drug dependence drug addiction intoxication withdrawal tolerance
More information*IN10 BIOPSYCHOSOCIAL ASSESSMENT*
BIOPSYCHOSOCIAL ASSESSMENT 224-008B page 1 of 5 / 06-14 Please complete this questionnaire and give it to your counselor on your first visit. This information will help your clinician gain an understanding
More informationALCOHOL USE DISORDER WITHDRAWAL MANAGEMENT AND LONG TERM TREATMENT ANA HOLTEY, MD ADDICTION MEDICINE FELLOW UNIVERSITY OF UTAH HEALTH
ALCOHOL USE DISORDER WITHDRAWAL MANAGEMENT AND LONG TERM TREATMENT ANA HOLTEY, MD ADDICTION MEDICINE FELLOW UNIVERSITY OF UTAH HEALTH Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV
More informationPediatric Psychopharmacology
Pediatric Psychopharmacology General issues to consider. Pharmacokinetic differences Availability of Clinical Data Psychiatric Disorders can be common in childhood. Early intervention may prevent disorders
More informationThe Biology of Addiction
The Biology of Addiction Risk factors for addiction: Biological/Genetic Family history of addiction Being male Having mental illness Exposure to substances in utero * The genes that people are born with
More informationMedication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users.
Slide #1 Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users. R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale AIDS Program Medical Director South Central Rehabilitation
More informationAddiction 101. Steve Hanson - Associate Commissioner NYS OASAS
Addiction 101 Steve Hanson - Associate Commissioner NYS OASAS After lunch Psychopharmacology Lecture Basic Questions Why do people do drugs? Why can t/ won t some people stop? Realities 1. People like
More informationMANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St.
MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St. Peter s Health Partners, Albany, NY Assistant Professor of Medicine,
More informationUnderstanding and Treating Behavioral Addictions
Understanding and Treating Behavioral Addictions Jon Grant, MD, JD, MPH Professor of Psychiatry and Behavioral Neuroscience University of Chicago Chicago, Illinois Disclosure The faculty have been informed
More informationIntro to Concurrent Disorders
CSAM-SCAM Fundamentals Intro to Concurrent Disorders Presentation provided by Jennifer Brasch, MD, FRCPC Psychiatrist, Concurrent Disorders Program, St. Joseph s Healthcare There are all kinds of addicts,
More informationMedication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment
Medication Assisted Treatment MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment Opioid Drugs Opium Morphine Heroin Codeine Oxycodone Roxycodone Oxycontin
More informationCell body, axon, dendrite, synapse
SOME BASIC NEUROSCIENCE Neurons have specialised extensions 1: Label the parts of a neuron by selecting the correct term from the box below. Cell body, axon, dendrite, synapse 1 dendrite synapse cell body
More informationWithdrawal.
Withdrawal Shamim Nejad, MD Director, Adult Burns & Trauma Psychiatry Division of Psychiatry and Medicine Medical Director, Addiction Consultation Team MGH Center for Addiction Medicine Massachusetts General
More informationSubstance Use and Addictive Disorders
Key Dates TU Feb 14 Unit 8 147-end and Unit 9; MW Ch 8 Jeffrey and Ch 10 Diana TH Feb 16 Unit 10; MW Ch 11 Theodore B TU Feb 21 Monday class schedule TH Feb 23 Begin Dimensions-Cognition, Units IIC and
More informationOpioids Research to Practice
Opioids Research to Practice CRIT Program May 2009 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin
More informationPharmacology of Addic0ve Disorders
Pharmacology of Addic0ve Disorders Thomas Kosten MD JH Waggoner Chair & Professor of Psychiatry, Pharmacology, Immunology, Pathology, Neuroscience & Epidemiology Baylor College of Medicine & MD Anderson
More informationSubstance Use Disorders
Substance Use Disorders Substance Use Disorder This is a 15 minute webinar session for CNC physicians and staff CNC holds webinars monthly to address topics related to risk adjustment documentation and
More informationBAPTIST HEALTH SCHOOL OF NURSING NSG 3036A: PSYCHIATRIC-MENTAL HEALTH
BAPTIST HEALTH SCHOOL OF NURSING NSG 3036A: PSYCHIATRIC-MENTAL HEALTH THERAPEUTIC INTERVENTION AND RESOURCE MANAGEMENT: SUBSTANCE RELATED DISORDERS: CO-DEPENDENCY AND THE IMPAIRED NURSE LECTURE OBJECTIVES:
More informationADHD & Addictions -What We Know
ADHD & Addictions -What We Know Dr. David Teplin, Psy.D., C.Psych. 4th CADDAC Annual Conference, Toronto October 14, 2012 1 Introduction Adult ADHD commonly co-exists with several other disorders, including
More informationModule II Opioids 101 Opiate Opioid
BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS Module II Opioids 101 Module II Goals of the Module This module reviews the following:! Opioid addiction and the brain!
More informationMark Edlund, MD, PhD RTI International. Photo courtesy of The Herb Museum, Vancouver, BC
Opioid Use Disorders and Their Treatment Mark Edlund, MD, PhD RTI International Photo courtesy of The Herb Museum, Vancouver, BC Acknowledgements Funded by NIDA R01 DA022560-01 NIDA R01 DA034627 NIDA R01
More informationSUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION
SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION What is the most important information I should know about SUBOXONE Film? Keep SUBOXONE Film in a secure place
More informationSAFE PRESCRIBING: RULES AND REGULATIONS. Michelle Y. Owens, MD MS State Board of Medical Licensure June 30, 2017
SAFE PRESCRIBING: RULES AND REGULATIONS Michelle Y. Owens, MD MS State Board of Medical Licensure June 30, 2017 DISCLOSURES I have no financial disclosures. OBJECTIVES Discuss the significance of the opiate
More informationThe Neurobiology of Addiction
The Neurobiology of Addiction Jodi Gilman, Ph.D. Center for Addiction Medicine Massachusetts General Hospital Associate Professor, Department of Psychiatry Harvard Medical School What is Addiction? commonly
More informationDSM-5 Table of Contents
DSM-5 Table of Contents DSM-5 Classification Preface Section I: DSM-5 Basics Introduction Use of DSM-5 Cautionary Statement for Forensic Use of DSM-5 Section II: Essential Elements: Diagnostic Criteria
More informationPolysubstance Use & Medication-Assisted Treatment
Polysubstance Use & Medication-Assisted Treatment DSM-V eliminated polysubstance disorder, instead specifying each drug of abuse and dependence. Substance-use disorder is a combination of the two DSM-IV
More informationThe Neurobiology of Drug Addiction
The Neurobiology of Drug Addiction Glen R. Hanson, Ph.D., D.D.S. Director, Utah Addiction Center Professor of Pharmacology and Toxicology, U of U Senior Advisor, NIDA Drug Abuse and Addiction are Among
More informationTHE ADDICTED BRAIN: WHAT S GOING ON IN THERE? 3 CE hours. Sandra Morgenthal, PCC-S, CCFC, RN Copyright 2016 Sandra Morgenthal All rights Reserved
THE ADDICTED BRAIN: WHAT S GOING ON IN THERE? 3 CE hours Sandra Morgenthal, PCC-S, CCFC, RN Copyright 2016 Sandra Morgenthal All rights Reserved You can contact this author at sandymorgenthal@yahoo.com
More informationSUBSTANCE USE DISORDER IN ADOLESCENT POPULATION
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences SUBSTANCE USE DISORDER IN ADOLESCENT POPULATION ANNABELLE SIMPSON, MD UNIVERSITY OF WASHINGTON GENERAL DISCLOSURES
More informationPrescription Opioid Addiction
CSAM-SCAM Fundamentals Prescription Opioid Addiction Presentation provided by Meldon Kahan, MD Family & Community Medicine University of Toronto Conflict of interest statement I received funds from Rickett
More informationOpioids Research to Practice
Opioids Research to Practice CRIT Program May 2008 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin
More informationUrine drug testing it s not always crystal clear
Urine drug testing it s not always crystal clear Kirk Moberg, MD, PhD, FASAM Executive Medical Director, UnityPoint Health Illinois Institute for Addiction Recovery Clinical Professor of Internal Medicine
More informationMedical Interventions for Addiction in Primary Care Settings. R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale University School of Medicine
Medical Interventions for Addiction in Primary Care Settings R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale University School of Medicine March 23, 2010 NIH Consensus on Drug Treatment Drug Addiction
More informationSubstance Use Disorders: What Can We Do to Help Break the Cycle of Addiction
Handout for the Neuroscience Education Institute (NEI) online activity: Substance Use Disorders: What Can We Do to Help Break the Cycle of Addiction Learning Objectives Identify patients who are dependent
More informationHOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain
Due to the high level of prescription drug use and abuse in Lake County, these guidelines have been developed to standardize prescribing habits and limit risk of unintended harm when prescribing opioid
More information10/27/09! Psychopharmacology 101 for the LADC! Disclosures! Lecture outline! Structural divisions of the nervous system!
Disclosures! Psychopharmacology 101 for the LADC! David A. Frenz, M.D.! Mental Health & Addiction Services! St. Josephʼs Hospital! I am employed by the HealthEast Care System! I do not have any financial
More information8/5/2013. MOSBIRT Annual Training The Big change in addiction medicine? Before we dive into pharmacotherapy
Medication Assisted Treatment for Substance Abuse in Primary Care Dan Vinson August 1, 2013 1 The Big change in addiction medicine? These diseases are rapidly becoming medical diseases. Done are the days
More informationUnderstanding the Impact of Drugs on Children. Jackie McReynolds Washington State University
Understanding the Impact of Drugs on Children Jackie McReynolds Washington State University Not all drug users are addicts... Addiction develops through several well-identified phases: No use at all (abstinence)
More informationDrug abuse: Drug misuse Dependence abuse
Drug abuse: Use of drugs for non-medical purposes Drug misuse: wrong use of drugs: Wrong choice Wrong dose & wrong duration e.g. misuse of antibiotics Dependence is associated with abuse 1 Repeated, periodic
More information7/3/2013 ABNORMAL PSYCHOLOGY SEVENTH EDITION CHAPTER ELEVEN CHAPTER OUTLINE. Substance Use Disorders. Oltmanns and Emery
ABNORMAL PSYCHOLOGY SEVENTH EDITION Oltmanns and Emery PowerPoint Presentations Prepared by: Ashlea R. Smith, Ph.D. This multimedia and its contents are protected under copyright law. The following are
More informationAMERICAN BOARD OF PSYCHIATRY AND NEUROLOGY, INC. PART I EXAMINATION IN PSYCHIATRY A AND B 2013 Content Outline
253 questions Percent Part A: Basic Concepts in Psychiatry I. Development through the life cycle 9% A. Infancy through adolescence 1. Personality development (e.g., moral development) 2. Developmental
More informationOpioids Research to Practice
Opioids Research to Practice May 2013 Daniel P. Alford, MD, MPH, FACP, FASAM Associate Professor of Medicine Assistant Dean, Continuing Medical Education Case 32 yo female brought in after heroin overdose
More informationWasted AN INTRODUCTION TO SUBSTANCE ABUSE
Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Dr. Brian L. Bethel Child and Family Therapist Independent Trainer and Consultant LPCC-S, LCDC III, RPT-S www.brianlbethel.com INTERPLAY COUNSELING & CONSULTING
More informationThe Brain, Behavior and Addiction National Family Dialogue January 27, 2010 Presenter: Flo Hilliard, MSH University of Wisconsin-Madison
The Brain, Behavior and Addiction National Family Dialogue January 27, 2010 Presenter: Flo Hilliard, MSH University of Wisconsin-Madison Attitudes about addiction and recovery throughout history Disease?
More informationOutcomes of Infants with Neonatal Abstinence Syndrome
Outcomes of Infants with Neonatal Abstinence Syndrome Caroline O. Chua, MD, FAAP Medical Director, Division of Neonatology Director, Neonatal Follow Up Clinic Nemours Children s Hospital Orlando, Florida
More informationDrugs and Society. Glen R. Hanson. Peter J. Venturelli. Annette E. Fleckenstein
Drugs and Society Glen R. Hanson Department of Pharmacology and Toxicology* University of Utah Salt Lake City, Utah Director of the Division of Neuroscience and Behavioral Research National Institute on
More informationSpecial Topic: Drugs and the Mind
BIOLOGY OF HUMANS Concepts, Applications, and Issues Fifth Edition Judith Goodenough Betty McGuire 8a Special Topic: Drugs and the Mind Lecture Presentation Anne Gasc Hawaii Pacific University and University
More informationDRUGS USED IN THE TREATMENT OF ADDICTION JOSEPH A. TRONCALE, MD FASAM RETREAT PREMIERE ADDICTION TREATMENT CENTERS
DRUGS USED IN THE TREATMENT OF ADDICTION JOSEPH A. TRONCALE, MD FASAM RETREAT PREMIERE ADDICTION TREATMENT CENTERS MAJOR CATEGORIES OF TREATMENTS Detoxification and Post-Acute Withdrawal Maintenance Co-Occurring
More informationDr. Renner receives honoraria from Reed Medical Education
Substance Use Disorders Symposium on Men s Health Massachusetts Medical Society June 17, 2010 John A. Renner, Jr., M.D. John A. Renner Jr., MD DISCLOSURES Johnson & Johnson Stock Holder Dr. Renner receives
More informationThe Biological Perspective. Jørg Mørland Senior researcher, Norwegian Institute of Public Health Professor em of Medicine University of Oslo
The Biological Perspective Jørg Mørland Senior researcher, Norwegian Institute of Public Health Professor em of Medicine University of Oslo The Biological Perspective What is it? More than «the» one biological
More informationUnderstanding Drug Abuse and Addiction. Steve Hanson - Associate Commissioner NYS OASAS
Understanding Drug Abuse and Addiction Steve Hanson - Associate Commissioner NYS OASAS Basic Questions Why do people do drugs? Why can t/ won t some people stop? Realities 1. People like Drugs. 2. We all
More informationDepression and Anxiety. What is Depression? What is Depression? By Christopher Okiishi, MD Spring Not just being sad A syndrome of symptoms
Depression and Anxiety By Christopher Okiishi, MD Spring 2016 What is Depression? Not just being sad A syndrome of symptoms Depressed mood Sleep disturbance Decreased interest in usual activities (anhedonia)
More informationCharles P. O Brien, MD, PhD University of Pennsylvania No financial conflicts, patents, speakers bureaus
Pain & Opioid Epidemic 2018 Charles P. O Brien, MD, PhD University of Pennsylvania No financial conflicts, patents, speakers bureaus Opioids 3400 BC Mesopotamia, Joy plant 1843 morphine by syringe 1874
More informationTable of Contents VOLUME 1
VOLUME 1 A Accidents and Injuries from Alcohol... 1 Accidents and Injuries from Drugs..... 4 Addiction: Concepts and Definitions... 7 Addictive Personality............... 12 Adolescents, Drug and Alcohol
More information2/21/2018. What are Opioids?
Opioid Crisis: South Carolina Responds Carolyn Bogdon, MSN, FNP-BC Coordinator for Emergency Department Medication Assisted Treatment Program Medical University of South Carolina Opioid Crisis: A Mounting
More informationMANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER
MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St. Peter s Health Partners Grand Rounds October 11, 2017 Disclosures One
More informationKurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center
Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Data from the National Vital Statistics System Mortality The age-adjusted rate of drug overdose deaths in the United States
More informationAsperger s Syndrome. severe difficulties interacting socially (Gillberg 2002). He named this difficulty
Julie Burton 7.16.2012 ED 243 Paper Asperger s Syndrome History In 1944 an Austrian pediatrician named Hans Asperger wrote an article about a group of school- aged boys when he discovered that some of
More information*Many of these DSM 5 Diagnoses might also be used to argue for eligibility using Other Health Impaired Criteria
Handout 2: DSM 5 Diagnoses that May be Associated with One or More of the Five ED Characteristics* 1. An inability to learn that cannot be explained by intellectual, sensory, or health factors. a) Selective
More informationOpioids Research to Practice
Opioids Research to Practice CRIT Program May 2010 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin
More informationAddiction Medicine: What s new for primary care
Addiction Medicine: What s new for primary care Dan Vinson, MD Family and Community Medicine How to talk so our patients listen, and listen so our patients talk. 1 2 Comfortably engaging your patient in
More informationTOOL 1: QUESTIONS BY ASAM DIMENSIONS
TOOL 1: QUESTIONS BY ASAM DIMENSIONS The following tool highlights specific questions that should be asked of the patient for each ASAM dimension. Name Date of Birth Date of Interview Address Referred
More informationPharmacotherapy of Substance Use Disorders in Children and Adolescents: Special Considerations
Pharmacotherapy of Substance Use Disorders in Children and Adolescents: Special Considerations Dr. Ajeet Sidana Department of Psychiatry Government Medical College & Hospital Chandigarh Scope of Presentation
More informationConcurrent Disorders
Concurrent Disorders Dr. Christy Sutherland MD CCFP dipabam Medical Director, PHS Community Services Methadone/Buprenorphine 101 Workshop April 1, 2017 Overview Introduction Epidemiology Treatment Principles
More informationAdolescents And Addiction
Adolescents And Addiction 1) According to the Substance Abuse and Mental Health Services Administration (SAHMSA), over million people over the age of 12 years needed treatment for substance use in 2012.
More informationThe Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome
Neonatal Nursing Education Brief: The Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome https://www.seattlechildrens.org/healthcareprofessionals/education/continuing-medical-nursing-education/neonatalnursing-education-briefs/
More information6B / Boswell, Grant and Slutske Day 2 August 14, 2008
Pharmacological Treatment of Pathological Gambling Jon E. Grant, JD, MD, MPH Associate Professor University of Minnesota School of Medicine Minneapolis, MN Disclosure Information I have the following financial
More informationHIBBING COMMUNITY COLLEGE COURSE OUTLINE
HIBBING COMMUNITY COLLEGE COURSE OUTLINE COURSE NUMBER & TITLE: PSYC 1400: Abnormal Psychology CREDITS: 3 (3Lec 0 / Lab) PREREQUISITES: PSYC 1205: General Psychology CATALOG DESCRIPTION: Abnormal Psychology
More informationAcknowledgements: What it is What it s not. Cannabis Evidence Series. Evidence-informed decision-making
Cannabis Evidence Series What it is What it s not Acknowledgements: The evidence presented is from the Cannabis evidence series authored by the HTA unit at the University of Calgary and from Rapid response
More informationSteve Hanson Associate Commissioner New York State Office of Alcoholism & Substance Abuse Services
Understanding Alcohol Abuse and Addiction Steve Hanson Associate Commissioner New York State Office of Alcoholism & Substance Abuse Services Steve.hanson@oasas.state.ny.us Agenda Understanding Alcohol/Drug
More informationBuprenorphine as a Treatment Option for Opioid Use Disorder
Buprenorphine as a Treatment Option for Opioid Use Disorder Joji Suzuki, MD Assistant Professor of Psychiatry Harvard Medical School Director, Division of Addiction Psychiatry Brigham and Women s Hospital
More informationCo-Occurring Disorders & Drug Addiction Basics: Identifying, Listening & Linking
Co-Occurring Disorders & Drug Addiction Basics: Identifying, Listening & Linking Sherry Larkins, Ph.D UCLA Integrated Substance Abuse Program June 24, 2011 1 Roadmap Overview of Co-Occurring Disorders
More informationBuprenorphine pharmacology
Buprenorphine pharmacology Victorian Opioid Management ECHO Department of Addiction Medicine St Vincent s Hospital Melbourne 2018 Page 1 Opioids full, partial, antagonist Full Agonists - bind completely
More informationAnalgesia for Patients with Substance Abuse Disorders. Lisa Jennings CN November 2015
Analgesia for Patients with Substance Abuse Disorders Lisa Jennings CN November 2015 Definitions n Addiction: A pattern of drug use characterised by aberrant drug-taking behaviours & the compulsive use
More informationUnderstanding Addiction and Dugs Of Abuse
Understanding Addiction and Dugs Of Abuse Wilkie A. Wilson, Ph.D. DukeLEARN wawilson@duke.edu There is a lot of epidemiological evidence that addiction begins before brain maturity, and lately some biological
More informationObjectives 11/2/2016. Managing Patients with Substance Abuse. Off Label Disclosure. Steven Shoptaw, PhD Professor Department of Family Medicine, UCLA
Managing Patients with Substance Abuse Steven Shoptaw, PhD Professor Department of Family Medicine, UCLA Objectives Epidemiology: Substances most likely to be misused in HIV care settings. Diagnostic and
More informationAdolescents And Addiction
Adolescents And Addiction 1) According to the Substance Abuse and Mental Health Services Administration (SAHMSA), over million people over the age of 12 years needed treatment for substance use in 2012.
More informationSlide 1. Slide 2. Slide 3. Opioid (Narcotic) Analgesics and Antagonists. Lesson 6.1. Lesson 6.1. Opioid (Narcotic) Analgesics and Antagonists
Slide 1 Opioid (Narcotic) Analgesics and Antagonists Chapter 6 1 Slide 2 Lesson 6.1 Opioid (Narcotic) Analgesics and Antagonists 1. Explain the classification, mechanism of action, and pharmacokinetics
More information